Prospective cohort study for safety and efficacy of low dose nab-paclitaxel
Not Applicable
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000013275
- Lead Sponsor
- Department of Surgical Oncology Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Past history of hypersensitivity for human serum albumin 2) Infectious disease that required systemic therapy 3) History of a severe heart disease 4) Poorly controlled diabetes mellitus 5) Peptic ulcer or gastrointestinal hemorrhage 6) Symptomatic brain metastsis 7) Pregnant, Lactating or possibility of pregnancy 8) History of drug allergy that may influenced with this treatment 9) In addition, the case that a investigator judged to be inadequate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Time to progression Overall response rate Overall survival